tbuckley/cabot-search huggingface dataset:
Assessment of Major Adverse Cardiac Events (MACE) and Arrhythmias in Patients with Large B-Cell Lymphoma Undergoing Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Impact of Baseline Cardiac Biomarkers
Authors: Haikoo Shah, Danielle O'Conke, Ran Zhao, Akansha Jalota, Manishkumar S. Patel, Allison Winter, Louis S. Williams, Jack Khouri, Deepa Jagadeesh, Faiz Anwer, Robert M. Dean, Betty K. Hamilton, Ronald M. Sobecks, Brad Pohlman, Paolo F. Caimi, Craig S. Sauter, Neetu Gupta, Brian T. Hill
Journal: Blood (2022)
Low Dose Dasatinib Is Not As Active in a CML CP Cohort Enriched with Intermediate/High-Risk CML Chronic Phase: A Phase IIb Multi-Center Trial
Authors: Aby Abraham, Hasmukh Jain, Jina Bhattacharyya, Dubashi Biswajit, Jayachandran PK, Dinesh Bhurani, Stalin Chowdary Bala, Suman Pramanik, Santhosh Devadas, Uday Prakash Kulkarni, Manju Sengar, Rayaz Ahmed, Thenmozhi Mani, Damodar Das, Parathan Karunakaran, Sadashivudu Gundeti, Rasmi Pallasseri, Nikhil Patkar, Manjunath Nookala, Smita Kayal, Poonkuzhali Balasubramanian
Journal: Blood (2022)
Ruxolitinib in Pediatric Patients with Treatment-<i>Naïve</i> or Steroid-Refractory Acute Graft-Versus-Host Disease: Primary Findings from the Phase I/II REACH4 Study
Authors: Franco Locatelli, Hyoung Jin Kang, Bénédicte Bruno, Virginie Gandemer, Fanny Rialland, Maura Faraci, Yoshiyuki Takahashi, Katsuyoshi Koh, Henrique Bittencourt, Grace Cleary, Christine Rosko, Pantelia Roussou, Annie St. Pierre, Anirudh Prahallad, Cristina Díaz-de-Heredia
Journal: Blood (2022)
Novel 17-Plex Flow Cytometry Assay for Comprehensive Immunophenotyping and Characterization of Plasma Cells (PC) in Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients
Authors: Iva Lelios, Enrique Gómez, Iryna Dekhtiarenko, Priscila Camillo Teixeira, Ann-Marie E Bröske
Journal: Blood (2022)
CLECL1+ CLL Cells: A Key Subset That Drives CLL Survival and Proliferation and Shapes a Th2-Biased Tumor Microenvironment
Authors: Shih-Shih Chen, Xiao-Jie Yan, Martina Cardillo, Anita Ng, Andrew Shih, Gonzalo Blanco, Morgan King-Richards, Yu-Ju Chen, Yasmine Kieso, Joanna M. Rhodes, Kanti R Rai, Nicholas Chiorazzi
Journal: Blood (2022)
Genetic Determinants of Isolated and Systemic Testicular Diffuse Large B-Cell Lymphoma Highlight a Disease Spectrum
Authors: Jasper Wong, Brett Collinge, Laura K Hilton, Susana Ben-Neriah, Merrill Boyle, Barbara Meissner, Kelly Mekwunye, Graham W. Slack, Pedro Farinha, Jeffrey W. Craig, Laurie H. Sehn, Diego Villa, Alina S. Gerrie, Andrew J. Mungall, Christian Steidl, James R. Cook, Andrew L. Feldman, Lisa M. Rimsza, Kerry J. Savage, Ryan D. Morin, David W. Scott
Journal: Blood (2022)
Real-Life Experience of Use of Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia. a Single Center Experience
Authors: Helena Pomares, Villarreal Hernandez Jasson, Susana Vives, Marta Cervera, Rosa Coll, Lurdes Zamora, Clara Maluquer, Gladys Ibarra, Julia Ribes Amoros, Georgina Gener-Ricós, Mercedes Galiano, Anna Sureda, Montserrat Arnan Sangerman
Journal: Blood (2022)
Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD), Combined with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Dose-Expansion Phase of the CC-92480-MM-001 Trial
Authors: Paul G. Richardson, Suzanne Trudel, Hang Quach, Rakesh Popat, Sagar Lonial, Robert Z. Orlowski, Kihyun Kim, María-Victoria Mateos, Charlotte Pawlyn, Karthik Ramasamy, Joaquín Martinez-Lopez, Alessia Spirli, Ignacio Casas-Avilés, Jing Gong, Michael Amatangelo, Jessica Katz, Paulo Maciag, Teresa Peluso, Nizar J. Bahlis
Journal: Blood (2022)
Response and Resistance to Cladribine in Patients with Advanced Systemic Mastocytosis: A Registry-Based Analysis
Authors: Johannes Lübke, Nicole Naumann, Sebastian Kreil, Georgia Metzgeroth, Hans-Peter Horny, Karl Sotlar, Nicholas C.P. Cross, Alice Fabarius, Peter Valent, Wolf-Karsten Hofmann, Juliana Schwaab, Andreas Reiter
Journal: Blood (2022)
A Prospective Study of Methotrexate in Combination with Ibrutinib and Temozolomide (MIT) in Newly Diagnosed Primary CNS Lymphoma
Authors: Xiaoxiao Wang, Changguo Shan, He Huang, Zhiming Li, Hui Zhou, Yan Gao, Shanshan Yu, Xiaoyu Hong, Mingyao Lai, Chao Yang, Yang Shao, Linbo Cai, Huiqiang Huang
Journal: Blood (2022)
Accuracy and Prediction of D-Dimers for Pulmonary Embolism in Patients with COVID-19 Infection
Authors: Damon E. Houghton, Ewa Wysokinska, Ana I. Casanegra, Leslie Padrnos, Surbhi Shah, Waldemar E. Wysokinski, Rajiv K. Pruthi, Heather A Heaton, Robert D. McBane
Journal: Blood (2022)
Allogeneic but Not Autologous Stem Cell Transplantation Improves Outcome in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma
Authors: Abdul-Hamid Bazarbachi, Daniel K. Reef, Hiba Narvel, Riya Patel, Rama Al Hamed, Astha Thakkar, Shafia Rahman, Urvi A Shah, Diego Adrianzen Herrera, Ryann Quinn, Sumaira Zareef, Emma Rabinovich, Alyssa De Castro, Felisha Joseph, Kailyn Gillick, Jennat Mustafa, Fariha Khatun, Amanda Lombardo, Latoya Townsend Nugent, Michelly Abreu, Nicole Chambers, Richard Elkind, Yang Shi, Yanhua Wang, Olga Derman, Kira Gritsman, Ulrich Steidl, Mendel Goldfinger, Noah Kornblum, Aditi Shastri, Ioannis Mantzaris, Lizamarie Bachier Rodriguez, Nishi Shah, Dennis Cooper, Ira Braunschweig, Amit Verma, B. Hilda Ye, Murali Janakiram, R. Alejandro Sica
Journal: Blood (2022)
Efficacy of Mesenchymal Stromal Cells for Refractory Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Ke Zhao, Zhiping Fan, Xiaoyong Chen, Yuan Chang, Li Xuan, Na Xu, Fen Huang, Pengcheng Shi, Ren Lin, Hui Liu, Jing Sun, Andy Peng Xiang, Qifa Liu
Journal: Blood (2022)
Revision of Complete Remission Criteria in Pediatric AML
Authors: Evangelia Antoniou, Annika Puschnig, Katharina Waack, Carolin Augsburg, Christel Katerkamp, Denise Kondryn, Tabea Ziedrich, Nils von Neuhoff, Dirk Reinhardt, Stephanie Sendker
Journal: Blood (2022)
Effective Antimicrobial Stewardship in Febrile Neutropenia: A Risk Stratification Tool Combining MASCC Score and Procalcitonin Measurements Reduces Antibiotic Duration and Length of Inpatient Stay for Haemato-Oncology Patients
Authors: Keir Pickard, Joanna Fawcett, Michelle Lannon, Thomas Creasey, Julie Samuel, Alexander Langridge, Nicola Redding, Meghan Acres, Gail Jones
Journal: Blood (2022)
B-Cell Targeting Anti-CD37 Humanized Antibodies Engineered for Potent Effector Functions and Extended Plasma Half-Life
Authors: Elisa Fiorito, Roman Generalov, Stian Foss, Helen Heyerdahl, Ada Repetto-Llamazares, Veronique Pascal, Geir E Tjønnfjord, Sigrid Strand Skånland, Jan Terje Andersen, Jostein Dahle
Journal: Blood (2022)
Tvt CAR7: Phase 1 Clinical Trial of Base-Edited "Universal” CAR7 T Cells for Paediatric Relapsed/Refractory T-ALL
Authors: Robert Chiesa, Christos Georgiadis, Giorgio Ottaviano, Farhatullah Syed, Toni Braybrook, Annie Etuk, Hong Zhan, Soragia Athina Gkazi, Roland Preece, Stuart Adams, Rebecca Thomas, Arnold Awuah, Kimberly Gilmour, Lana Mhaldien, Jan Chu, Danielle Pinner, Agnieszka Kubat, Paul Veys, Kanchan Rao, Giovanna Lucchini, David O'Connor, Ajay Vora, Waseem Qasim
Journal: Blood (2022)
Single and Combinational Multiplex Base-Edited 'Universal' CAR T Cells in a Humanised Model of Primary CD7+CD33+ AML
Authors: Arnold Kloos, Christos Georgiadis, Annie Etuk, Soragia Athina Gkazi, Farhatullah Syed, Toni Braybrook, Hong Zhan, Renuka Kadirkamanathan, Nadine Kattre, Kerstin Görlich, Thomas Fangmann, Axel Schambach, Martin G. Sauer, Michael Heuser, Waseem Qasim
Journal: Blood (2022)
Time to Diagnosis and Treatment in an Underserved, Predominantly Hispanic Population of Adults in East Los Angeles- a Retrospective Study of Acute T- Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Patients
Authors: Madeline Macdonald, Matthew Juarez, Julian Hardy McLain, Maria E. Vergara-Lluri, Imran Siddiqi, Upama Giri, Han Tun, Zaw Win Myint
Journal: Blood (2022)
Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis
Authors: Mahek Garg, Ambika Satija, Yan Song, Eric Sarpong, Ben Meade, Esteban Lemus-Wirtz, Katherine Gaburo, James E. Signorovitch, Monika Raut, Katherine Elizabeth Ryland, Samhita Chakraborty
Journal: Blood (2022)
ATG-Ptcy-CSA for Gvhd Prevention in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation for Adults with Hematological Malignancies
Authors: Maria Queralt Salas, Abel Santos Carreira, Eshetu G. Atenafu, Tommy Alfaro Moya, Arjun D. Law, Wilson Lam, Ivan Pasic, Carol Chen, Dennis Dong Hwan Kim, Fotios V. Michelis, Armin Gerbitz, Jeffrey H. Lipton, Rajat Kumar, Jonas Mattsson, Auro Viswabandya
Journal: Blood (2022)
Stimulus MDS-US Trial in Progress: Evaluating Sabatolimab in Combination with Hypomethylating Agents (HMAs) in Patients with Intermediate-, High-, or Very High-Risk Myelodysplastic Syndrome (MDS)
Authors: Amer M. Zeidan, Amy E. DeZern, Uma Borate, Krissy Kobata, Susan E. Ide, John Sabo, Pedro Marques Ramos, Haiying Sun, Roger M. Lyons, Guillermo Garcia-Manero
Journal: Blood (2022)
Impact of a Validated Composite Comorbidity Score on Outcomes in Patients Treated with CAR T-Cell Therapy for Diffuse Large B Cell Lymphoma (DLBCL): A Multicenter Real-World Evidence (RWE) Study
Authors: Geoffrey Shouse, Andy Kaempf, Max J. Gordon, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey A. Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S Kittai, Alexey V Danilov
Journal: Blood (2022)
Real-World Treatment Patterns and Costs of Chimeric Antigen Receptor (CAR) T Cell Therapies, Polatuzumab Vedotin-Piiq (Pola), and Tafasitamab-Cxix (Tafa) in Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: Fei Fei Liu, Krishnaveni Subbiah, Tao Gu, Trong Kim Le
Journal: Blood (2022)
Real-World Treatment Patterns and Clinical Outcomes with Brentuximab Vedotin or Other Standard Therapies in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL): A Retrospective Chart Review Study in the United States
Authors: Stefan K. Barta, Nicholas Liu, Maral DerSarkissian, Rose Chang, Mingchen Ye, Mei Sheng Duh, Andy Surinach, Michelle A. Fanale, Kristina S. Yu
Journal: Blood (2022)
Preliminary Results of the Filo Phase 2 Trial for Untreated Fit Patients with Intermediate Risk Chronic Lymphocytic Leukemia Comparing Ibrutinib Plus Venetoclax (IV) Versus FCR: Results of the Month 15 MRD Evaluation
Authors: Anne Quinquenel, Rémi Letestu, Magali Le Garff-Tavernier, Fabien Subtil, Therese Aurran-Schleinitz, Kamel Laribi, Florence Cymbalista, Vincent Levy, Laurence Simon, Damien Roos-Weil, Véronique Leblond, Marie-Sarah Dilhuydy, Caroline Dartigeas, Cecile Tomowiak, Romain Guieze, Olivier Tournilhac, Emmanuelle Ferrant, Sophie de Guibert, Pierre Feugier, Fatiha Merabet, Stephane Lepretre, Philippe Carassou, Julie Gay, Bénédicte Hivert, Luc Mathieu Fornecker, Jehan Dupuis, Lysiane Molina, Bruno Villemagne, Guillaume Cartron, Bernard Drenou, Béatrice Mahé, Omar Benbrahim, Xavier Cahu, Christelle Portois, Loic Ysebaert, Florence Nguyen Khac, Valérie Rouille, Alain Delmer, Anne-Sophie Michallet
Journal: Blood (2022)
Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
Authors: Shipra Goel, Brahm Segal, Elizabeth A. Griffiths, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Matthew J Cortese, Paola Ghione, Michael J. Nemeth, Jason Muhitch
Journal: Blood (2022)
Fine-Mapping of <i>SMAD6</i> Sequence Data Identifies Additional Putative Risk Loci for Langerhans Cell Histiocytosis
Authors: Erin Peckham-Gregory, Priya B Shetty, Howard Lin, Brooks Scull, Erik Ehli, Kenneth L. McClain, Philip J. Lupo, Carl E. Allen, Michael E. Scheurer
Journal: Blood (2022)
Disease Characterization and Response Prediction in Myeloma Patients Undergoing Conventional and Cellular Therapies from Circulating Tumor DNA
Authors: Hitomi Hosoya, Mia Carleton, Kailee L Tanaka, Brian Sworder, Vanna Hovanky, George E Duran, Tian Y. Zhang, Michael S. Khodadoust, David B. Miklos, Sally Arai, David Iberri, Michaela Liedtke, Surbhi Sidana, David M. Kurtz
Journal: Blood (2022)
Magrolimab, Rituximab and Acalabrutinib for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Phase 1 PRISM Trial
Authors: Sven de Vos, Patrick M. Reagan, Manish R. Patel, Nakhle S. Saba, Andrew Mortlock, Virginie Cerec, Veerendra Munugalavadla, Melih Acar, Barrett Nuttall, David Jenkins, Rafael White, Megan Callahan, Alessandra Forcina, Mark Roschewski, Ian W. Flinn
Journal: Blood (2022)
HDAC8 Disrupts DNA Damage Response By Deacetylation of U2AF1 in Inv(16) Acute Myeloid Leukemia
Authors: Lianjun Zhang, Le Xuan Truong Nguyen, Wei-Kai Hua, Yinghui Zhu, Ying-Chieh Chen, Xin He, Man Li, Yu-Hsuan Fu, Haojie Dong, Bin Zhang, Ling Li, Jeremy Stark, Guido Marcucci, Ya-Huei Kuo
Journal: Blood (2022)
Identification of Key microRNAs As Predictive Biomarkers of Nilotinib Response in Chronic Myeloid Leukemia: A Sub-Analysis of the Enestxtnd Clinical Trial
Authors: Andrew Wu, Ryan Yen, Sarah Grasedieck, Hanyang Lin, Jiechuang Su, Katharina Rothe, Helen Nakamoto, Donna L. Forrest, Connie J. Eaves, Xiaoyan Jiang
Journal: Blood (2022)
MRD Status and ELN 2022 Predicts for Outcomes of Venetoclax + Hypomethylating Therapy in AML: Single-Center Real-World Analysis
Authors: Mark G. Faber, Jeffrey Baron, Han Yu, Hassan Awada, Tara L. Cronin, James E. Thompson, Amanda Przespolewski, Steven D. Green, Pamela J. Sung, Elizabeth A. Griffiths, Eunice S. Wang
Journal: Blood (2022)
Safety, Efficiency and Long-Term Follow-up of AUTO1, a Fast-Off Rate CD19 CAR in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia and Other B-Cell Malignancies
Authors: Claire Roddie, Juliana Dias Alves Pinto, Maeve A O'Reilly, Marina Mitsikakou, Eftychia Charalambous, Louisa Green, Mhairi Vaughan, Giulia Agliardi, John Garcia, Evie Lewin, Mark W. Lowdell, Maria A V Marzolini, Leigh Wood, Helen Holmes, Yenting Ngai, Bilyana Popova, William Wilson, Sangeetha Kunaseelan, Victoria Spanswick, Helen Lowe, Leah Ensell, John A. Hartley, Simon Morley, David C. Linch, Adrian Bloor, David A. Irvine, Martin Pule, Karl S Peggs
Journal: Blood (2022)
The IL7R-Antagonist OSE-127 Blocks Acute Lymphoblastic Leukemia Development Via a Dual Mode of Action
Authors: Lennart Lenk, Irène Baccelli, Dorothee Winterberg, Anna Dietterle, Frédérique Corallo, Julien Taurelle, Emma Narbeburu, Anna Laqua, Beat Bornhauser, Jean-Pierre Bourquin, Fotini Vogiatzi, Martin Schrappe, Gunnar Cario, Monika Brüggemann, Nicolas Poirier, Denis Martin Schewe
Journal: Blood (2022)
Inferior Outcomes of EU Vs. US Patients with Relapsed/Refractory Large B-Cell Lymphoma after CD19 CAR T-Cell Therapy Are Associated with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization and CAR-T Product Selection
Authors: Veit L Buecklein, Ariel Perez-Perez, Kai Rejeski, Gloria Iacoboni, Vindi Jurinovic, Udo Holtick, Olaf Penack, Soraya Kharboutli, Viktoria Blumenberg, Josephine Ackermann, Lisa Frölich, Grace Johnson, Kedar Patel, Brian Arciola, Christian Schmidt, Omar Albanyan, Philipp Gödel, Eva Hoster, Lars Bullinger, Andreas Mackensen, Frederick L. Locke, Michael von Bergwelt, Pere Barba, Michael D. Jain, Marion Subklewe
Journal: Blood (2022)
Single-Cell RNA-Seq Reveals an Interferon-Driven Inflammatory CD4 Naïve T Cell Subpopulation at Day 100 in Hematopoietic Stem Cell Transplant Patients That Ultimately Develop Chronic Gvhd
Authors: Alexandre Albanese, Edward Chen, Jillian Zavistaski, Kayla Betz, Yvonne Suessmuth, Lorenzo Cagnin, Paula Keskula, Kyle Kimler, James Kaminski, Bruce R. Blazar, Benjamin Watkins, Leslie S. Kean
Journal: Blood (2022)
A Novel Inhibitor of FLT3 and Its Drug-Resistant Mutants with Superior Activity to Gilteritinib in Molm-13 Preclinical Acute Myeloid Leukemia Xenograft Model
Authors: Ola A Elgamal, James R Lerma, Allison Mullaney, Emily Stahl, Blaise Stearns, Andrew Orry, Polo Chun-Hung Lam, Ruben Abagyan, Alexei Pushechnikov, Nikolay Savchuk, Volodymyr Kysil, Hovhannes Gukasyan, Iain Dukes, Oleg Mitkin, Ruben Karapetian, Alexei Riakhovskii, Elena Bulanova, Vladislav Parchinsky, Alexandre Ivachtchenko, Sharyn Baker, Erin Hertlein, John C. Byrd
Journal: Blood (2022)
Characterization of Patients with Lower-Risk Myelodysplastic Syndromes Experiencing Long-Term Responses with Luspatercept in the MEDALIST Study
Authors: Uwe Platzbecker, Valeria Santini, Rami S. Komrokji, Amer M. Zeidan, Guillermo Garcia-Manero, Rena Buckstein, Esther Natalie Oliva, Dimana Miteva, Veronika Pozharskaya, Xianwei Ha, Jose Alberto Nadal, Pierre Fenaux
Journal: Blood (2022)
A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan Using Prince Trial Data Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria
Authors: Raymond Wong, Jesse Fishman, Koo Wilson, Mohammed Al-Adhami, Michael Yeh, Zalmai Hakimi, Christopher Yee, Lynn Huynh, Mei Sheng Duh
Journal: Blood (2022)
Randomized Phase II Study to Assess the Role of Nivolumab As Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients after Chemotherapy (NCI9706 protocol; REMAIN Trial)
Authors: Hongtao Liu, Elad Sharon, Theodore G. Karrison, Yuanyuan Zha, Noreen Fulton, Howard Streicher, Kendra Sweet, George Yaghmour, Jane Jijun Liu, Brian A. Jonas, Aaron D. Schimmer, Steven Grant, Amer M. Zeidan, Gerhard C. Hildebrandt, Christopher S. Hourigan, Christopher H. Lowrey, Ryan J. Mattison, Neil Palmisiano, Amandeep Salhotra, Dimitrios Tzachanis, Maria R. Baer, Tara L. Lin, Prapti Patel, Helen Chen, Walter M. Stadler, Olatoyosi Odenike, Richard A. Larson, Thomas F. Gajewski, Wendy Stock
Journal: Blood (2022)
Expansion of a CD8+ Temra Population and Activating T-Cell Interactions Characterize the Graft Versus Leukemia Response in Relapsed AML
Authors: Katie Maurer, Cameron Y. Park, Mehdi Borji, Shouvik Mani, Jackson Southard, Samouil L. Farhi, Domenic Abbondanza, Shuqiang Li, Kenneth J. Livak, Jerome Ritz, Robert J. Soiffer, Pavan Bachireddy, Catherine J. Wu, Elham Azizi
Journal: Blood (2022)
Deletion of Micro RNA-15/16 Clusters Promotes Leukemic Initiation in AML Via the Deregulation of Hematopoietic Progenitors
Authors: Anita Ng, Yuhong Ma, Yuri Pekarsky, Francesca Lovat, Frank Di Caro, Esha Sharma, Lita Crichton, Britta Will, Carlo M. Croce, Nicholas Chiorazzi
Journal: Blood (2022)
Mutant <i>Srsf2</i> Diminishes <i>Jak2V617F</i>-Induced Erythrocytosis in Mice and Is Associated with Lower Hemoglobin in Patients with Chronic Phase <i>JAK2</i>-Mutant MPN
Authors: Anna E Marneth, Jonas S. Jutzi, Chulwoo J. Kim, Charles Laurore, Anastasia Tishena, Frederike Kramer, Azucena V. Rocha, Mohammed Wazir, Lachelle D. Weeks, Joan How, Maximilian F. Stahl, Marlise R. Luskin, R. Coleman Lindsley, Olga Pozdnyakova, Timothy A. Graubert, Ann Mullally
Journal: Blood (2022)
IRF4 Shapes the Tumor Microenvironment of Follicular Lymphoma
Authors: Patrizia Mondello, Kerstin Wenzl, Zhi-Zhang Yang, Changjin Hong, Jordan E. Krull, Xinyi Tang, Vaishali Bhardwaj, Joseph P. Novak, Hyojin Kim, Prithviraj Mukherjee, Rebecca L. King, Tae Hyun Hwang, Mark J Shlomchik, Anne J. Novak, Stephen M. Ansell
Journal: Blood (2022)
STP938, a Selective CTPS1 Inhibitor, Shows Single Agent Activity and Synergy with BCL2 Inhibition in Preclinical Models of Mantle Cell Lymphoma
Authors: David Chiron, Emmanuelle Menoret, Charlotte Kervoelen, Sophie Maïga, Celine Bellanger, Benoit Tessoulin, Cyrille Touzeau, Hélène Asnagli, Andy Parker, Philip Beer, Catherine Pellat-Deceunynck
Journal: Blood (2022)
Utilizing TCR-Seq to Detect Tabelecleucel, an Allogeneic Epstein-Barr Virus (EBV)-Specific T-Cell Immunotherapy, Post-Infusion
Authors: Fiona Ruiz, Tassja J. Spindler, Sumer Arthurs, Tiffany Jehng, Kate Widmann, Joseph M. Benoun, Yuanbin Ru, Aditi Mehta, Rajani Dinavahi, Jason A. Dubovsky, Cokey Nguyen
Journal: Blood (2022)
Quality of Life Trajectories in Patients Treated with R-CHOP for Diffuse Large B-Cell Lymphoma As Part of the Remodl-B Trial (ISRCTN 51837425)
Authors: Joanna Hack, Inês Ralha, Sam Wilding, Louise Stanton, Josh Caddy, Sharon Barrans, Christoph Mamot, Urban Novak, Cathy Burton, Pamela McKay, Gavin Campbell, Andrew Davies, Peter Johnson
Journal: Blood (2022)
Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
Authors: Guangshuai Teng, Yuhui Zhang, Chenxiao Du, Yan Wang, Naibo Hu, Yingdi Han, Jinyu Ma, Shan Gao, Guangpeng Xiang, Zonghong Shao, Jie Bai
Journal: Blood (2022)
A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD+ AML or ALL or Poor/Very Poor Risk MDS
Authors: Sawa Ito, Christine Voigt, Constantinos Panousis, Tim Mayall, Mark Shlomchik, Jennifer Roy, Egidio Brocca Cofano, Stephanie Stras, David Apelian, Warren D Shlomchik
Journal: Blood (2022)
Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study
Authors: Ingigerdur S Sverrisdottir, Sigrún Thorsteinsdóttir, Sæmundur Rögnvaldsson, Thor Aspelund, Brynjar Vidarsson, Páll Torfi Önundarson, Bjarni Agnarsson, Margrét Sigurdardóttir, Ingunn Thorsteinsdottir, Signy Vala Sveinsdottir, Robert Palmason, Ísleifur Ólafsson, Fridbjorn Sigurdsson, Ásdis Rósa Thórdardottir, Elias Eythorsson, Asbjorn Jonsson, Runolfur Palsson, Olafur Skuli Indridason, Gauti Kjartan Gislason, Andri Olafsson, Jon Kristinn Sigurdsson, Hlif Steingrimsdottir, Thorir Einarsson Long, Malin Hultcrantz, Brian G.M. Durie, Stephen Harding, Ola Landgren, Sigurdur Y Kristinsson, Thorvardur Jon Love
Journal: Blood (2022)
Comparison of Activated Clotting Time to Hepcon Protamine Titration for Anticoagulation Management during Cardiopulmonary Bypass Surgery in a Patient with Severe Hemophilia a on Emicizumab Prophylaxis
Authors: Ellen Cusano, Haowei Linda Sun, M Dawn Goodyear, Man-Chiu Poon, Douglas Seal, R Scott McClure, Natalia Rydz
Journal: Blood (2022)
Functional Connectivity and Executive Function Abilities Strengthen without Change in Structural Connectivity after Transfusion in Children with Sickle Cell Disease
Authors: Landon C. Power, Amy E. Mirro, Michael M. Binkley, Kristin P. Guilliams, Josiah B. Lewis, Jade Beshears, Andria L. Ford, Joshua S. Shimony, Hongyu An, Jin-Moo Lee, Melanie E. Fields
Journal: Blood (2022)
Real-World Treatment Experience of Venetoclax in Combination with Hypomethylating Agents in Patients with Newly Diagnosed Acute Myeloid Leukemia: Updated Experience from a Predominately Community Setting in the US
Authors: Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Wei-Han Cheng, Michael Werner, Jonathan Abbas, William Donnellan
Journal: Blood (2022)
Urinary C-Telopeptide of Type II Collagen As a Marker of Avascular Necrosis in Younger and Older Adults with Sickle Cell Disease
Authors: Rania E. Mohamed, Charity I. Oyedeji, Richard Faldowski, Virginia Byers Kraus, Janet Huebner, Stephanie Padrick, Reena Ravi, Arvind Subramaniam, John J. Strouse
Journal: Blood (2022)
High Potency Vasoactive Intestinal Peptide Receptor Antagonists Induce Durable Antileukemia/Tumor T Cell Memory in Mice with Once Daily Dosing
Authors: Jian-Ming LI, Tenzin Passang, Pankoj Kumar Das, Shuhua Wang, Anish Sen-Majumdar, Nikolaos Papadantoonakis, Cynthia R. Giver, Edmund K. Waller
Journal: Blood (2022)